2022
DOI: 10.14309/01.ajg.0000860380.53066.b0
|View full text |Cite
|
Sign up to set email alerts
|

S935 Efficacy and Safety of Etrolizumab in Treatment of Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Clinical Trials

Abstract: DVT) (OR 1.24), interstitial lung disease (ILD) (OR 1.14), chronic kidney disease (CKD) (OR1.43), uveitis (OR 2.65), episcleritis (OR 1.78) and autoimmune hepatitis (AIH) (OR 1.54) . However, psoriasis (OR 0.49), vasculitis (OR 0.87) , ankylosing spondylitis (OR 0.82) and osteoporosis (OR 0.63) were less common in African American IBD patients (Table ). Conclusion: Our large cohort of IBD patients demonstrates significant racial differences in the prevalence of EIM of IBD in the United States. The association … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles